Case Study:
Our population level report for a regional MAT program revealed trends and patterns that are beyond what individual results can show.
Non-opioid substance use (cocaine) quietly undermines the success of Methadone treatment.
The program now proactively risk-stratifies stimulant users.
Fentanyl users enrolled in the MAT program show a complex pattern of poly-substance use that includes both sedatives and stimulants.
Suboxone and Naltrexone patients within the same facility show simpler, more focused patterns of drug use.
Acutis has created a high-specificity presumptive screen: Acutis Ultradetect
Across the industry, outdated presumptive immunoassay screening routinely misses key drug use events due to high cutoff thresholds, poor cross-reactivity, and inconsistent performance.
The presumptive screen precedes confirmatory testing. However, when a faulty presumptive screen test fails to detect drug use, the opportunity for a reflex to confirmation, and clinical action, is lost.
Acutis UltraDetect™ replaces outdated immunoassay presumptive screening with high-specificity technology that catches what traditional presumptive screens miss.
“
We have solved an industry-wide problem with a high-specificity presumptive screen.
For many years, drug testing involved immunoassay presumptive screens, which are subject to false positives and false negatives.
By engineering a high-specificity presumptive screen,
we’ve eliminated these blind spots.
Ph.D., DABCC, FACB
Acutis Ultradetect™ Advantage
Our scientists have analyzed the most common failure points
in traditional immunoassay using presumptive drug screening.
Here is how Acutis Ultradetect solves the poor specificity for Benzodiazepines when using traditional immunoassay presumptive screens.
Read our complete study on how UltraDetect compares with traditional Presumptive Immunoassay test.
Our Confirmatory Testing Delivers:
- Low cut-off levels
- Expanded drug coverage
- Rapid turnaround
Acutis offers a comprehensive confirmatory testing menu designed to eliminate the gaps commonly seen across the industry.
Tianeptine
(“Gas Station Heroin”)
7-Hydroxymitragynine
(7-OH)
Thebaine
Distinguishes between morphine positive from the NY bagel versus drug use
Go Beyond Test Results
with Population-Level Insight.
Are Really Using.
Real-time insights into evolving substance use patterns across your population. Identify co-use trends, emerging risks, and inconsistencies, before they impact outcomes.
Population Pulse gives you visibility beyond the test result.
Population Pulse Excerpt
Polysubstance Use Is the New Reality.
Heroin is rarely used alone.
A majority of heroin samples also test positive for other substances, most commonly fentanyl analogs and cocaine, reflecting a growing trend of polysubstance use.
- Mixing of heroin with other illicit drugs is increasingly common
- Cocaine use is rising alongside the trend of speedballing
- Co-use increases risk and complicates treatment decisions
Samples Processed
Patients Served
Decades
of Commitment
to Getting It Right
Know What Your Patients Are Actually Using
Trusted by providers nationwide for high-sensitivity clinical toxicology testing and actionable reporting.
Stop relying on incomplete screening. Start testing with Acutis.
Simple to Start. Easy to Scale.
with Acutis
samples
clinical insights
